O

OrbiMed Portfolio holdings

AUM $3.98B
1-Year Est. Return 13.05%
This Quarter Est. Return
1 Year Est. Return
+13.05%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.88B
AUM Growth
-$2.53B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
148
New
Increased
Reduced
Closed

Top Buys

1
+$106M
2
+$80.2M
3
+$77.8M
4
RYTM icon
Rhythm Pharmaceuticals
RYTM
+$43.5M
5
SCPH
scPharmaceuticals
SCPH
+$41.2M

Top Sells

1
+$172M
2
+$171M
3
+$127M
4
MRK icon
Merck
MRK
+$105M
5
GILD icon
Gilead Sciences
GILD
+$101M

Sector Composition

1 Healthcare 91.38%
2 Financials 1.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$392M 4.96%
1,230,700
-399,300
2
$344M 4.36%
2,879,575
-765,911
3
$321M 4.06%
854,600
+281,830
4
$320M 4.04%
3,062,850
-289,127
5
$261M 3.3%
1,741,300
-333,002
6
$257M 3.26%
10,386,600
-3,010,400
7
$226M 2.85%
1,297,100
+44,000
8
$216M 2.73%
2,184,535
-241,200
9
$204M 2.58%
3,799,419
-1,950,957
10
$198M 2.5%
10,425,225
11
$197M 2.49%
969,300
-296,800
12
$193M 2.44%
2,288,000
-787,000
13
$173M 2.19%
2,590,700
-1,048,200
14
$152M 1.92%
6,852,068
-2,094,166
15
$148M 1.87%
658,718
-268,900
16
$137M 1.73%
8,461,727
-1,535,089
17
$135M 1.71%
3,367,315
18
$134M 1.7%
1,971,670
-417,000
19
$129M 1.63%
4,129,638
20
$127M 1.6%
3,372,300
-799,800
21
$120M 1.51%
941,600
-143,200
22
$102M 1.29%
1,041,488
-272,300
23
$102M 1.29%
1,050,600
-914,400
24
$97.6M 1.23%
7,621,400
-6,561,500
25
$89.6M 1.13%
9,417,715
-935,981
1
2 3 4 5